Picture of Biocorrx logo

BICX Biocorrx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biocorrx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.58-6.05-3.51-5.21-4.38
Depreciation
Non-Cash Items4.623.20.8990.9051.73
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.128-0.1190.3780.7040.578
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.83-2.94-2.15-3.54-2.04
Capital Expenditures-0.056-0.123-0.009-0.050
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0010
Sale of Fixed Assets
Cash from Investing Activities-0.056-0.122-0.009-0.050
Financing Cash Flow Items602.25-0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.155.420.1073.082.02
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.2682.37-2.05-0.506-0.017